Keytruda is the first and only anti-PD-1 therapy approved in combination with chemoradiotherapy for these patients
The workshop was conducted as a part of the NITI–State workshop series
The R&D centre is mainly dedicated to the Process R&D of New Chemical Entities (NCE) development projects
Argo will receive upfront payments of US$ 185 million from Novartis and is eligible to receive potential option and milestone payments as well as tiered royalties on commercial sales.
He is also inducted as a member of the management council and senior management personnel of the company
The three-day forum will feature global leaders, scientists, regulatory body representatives, industry associations, and academia among many others
Doxazosin tablets are indicated for the treatment of hypertension, to lower blood pressure
HIFU is a state-of-the-art treatment that utilizes high-frequency sound waves to target and destroy prostate cancer cells
Submission based on positive results from global phase 3 study demonstrating overall survival benefit of TIVDAK over chemotherapy
The primary goal of this joint venture is to develop and commercialise novel cell therapy products for major unmet medical needs in the United States, Japan, and EU regions
Subscribe To Our Newsletter & Stay Updated
